drugset / Trial / NCT06576765
Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the pharmacokinetics (PK), safety, and tolerability of a single oral dose of AZD0780 with moderate and possibly mild hepatic impairment in comparison to a matched healthy control group.
Timeline
- Start
- 2024-08-08
- Primary completion
- 2024-11-08
- Completion
- 2024-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Laroprovstat | Small molecule | — | Oral |
Indications
No indication recorded.